Validation of Manufacturing NKG2D Chimeric Antigen Receptor T Cells for a First-In-Human Clinical Trial in AML/MDS and Multiple Myeloma

被引：0
|
作者：
Daley, Heather [1 ]
Nikiforow, Sarah [1 ,2 ]
Murad, Joana [3 ]
Negre, Helene [1 ]
Reider, Jake [3 ]
Sentman, Charles [4 ]
Snykers, Sarah [5 ]
Allen, Rachel [5 ]
Galinsky, Ilene [1 ]
Munshi, Nikhil [1 ,2 ]
Stone, Richard [1 ,2 ]
Soiffer, Robert [1 ,2 ]
Ritz, Jerome [1 ,2 ]
Baumeister, Suzanne [1 ,2 ,6 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Celdara Med LLC, Lebanon, NH USA
[4] Geisel Sch Med Dartmouth, Hanover, NH USA
[5] Celyad SA, Mont St Guibert, Belgium
[6] Boston Childrens Hosp, Boston, MA USA
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)32880-5
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
71
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma
    Nikiforow, Sarah
    Murad, Joana
    Daley, Heather
    Negre, Helene
    Reder, Jake
    Sentman, Charles L.
    Lehmann, Frederic
    Snykers, Sarah
    Allen, Rachel
    Galinsky, Ilene
    Munshi, Nikhil C.
    Stone, Richard M.
    Soiffer, Robert
    Ritz, Jerome
    Baumeister, Susanne H. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma
    Nikiforow, Sarah
    Werner, Lillian
    Murad, Joana
    Jacobs, Matthew
    Johnston, Lauren
    Patches, Sarah
    White, Randie
    Daley, Heather
    Negre, Helene
    Reder, Jake
    Sentman, Charles
    Wade, Terri
    Schmucker, Adam
    Lehmann, Frederic Francois
    Snykers, Sarah
    Allen, Rachel
    Dipietro, Heidi
    Cummings, Kristen
    Galinsky, Ilene
    Munshi, Nikhil C.
    Schlossman, Robert L.
    Stone, Richard M.
    Neuberg, Donna S.
    Soiffer, Robert J.
    Dranoff, Glenn
    Ritz, Jerome
    Baumeister, Susanne H. C.
    BLOOD, 2016, 128 (22)
  • [3] Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma
    Barber, Amorette
    Zhang, Tong
    Megli, Christina J.
    Wu, Jillian
    Meehan, Kenneth R.
    Sentman, Charles L.
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (10) : 1318 - 1328
  • [4] Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
    Baumeister, Susanne H.
    Murad, Joana
    Werner, Lillian
    Daley, Heather
    Trebeden-Negre, Helene
    Gicobi, Joanina K.
    Schmucker, Adam
    Reder, Jake
    Sentman, Charles L.
    Gilham, David E.
    Lehmann, Frederic F.
    Galinsky, Ilene
    DiPietro, Heidi
    Cummings, Kristen
    Munshi, Nikhil C.
    Stone, Richard M.
    Neuberg, Donna S.
    Soiffer, Robert
    Dranoff, Glenn
    Ritz, Jerome
    Nikiforow, Sarah
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (01) : 100 - 112
  • [5] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    A Barber
    K R Meehan
    C L Sentman
    Gene Therapy, 2011, 18 : 509 - 516
  • [6] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    Barber, A.
    Meehan, K. R.
    Sentman, C. L.
    GENE THERAPY, 2011, 18 (05) : 509 - 516
  • [7] NKG2D chimeric antigen receptor-T cells to target GBM.
    Dai, Hong-jiu
    Yang, Dong
    Sun, Bin
    Shi, Lan
    Zhang, Pei-xian
    Zhao, Xu-dong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy
    Murad, Joana M.
    Baumeister, Susanne H.
    Werner, Lillian
    Daley, Heather
    Trebeden-Negre, Helene
    Reder, Jake
    Sentman, Charles L.
    Gilham, David
    Lehmann, Frederic
    Snykers, Sarah
    Sentman, Marie-Louise
    Wade, Terri
    Schmucker, Adam
    Fanger, Michael W.
    Dranoff, Glenn
    Ritz, Jerome
    Nikiforow, Sarah
    CYTOTHERAPY, 2018, 20 (07) : 952 - 963
  • [9] Chimeric antigen receptor T cell therapy targeting NKG2D ligand
    Asao, Tetsuhiko
    Ishibashi, Rie
    Inoue, Moeko
    Fuse, Masafumi
    Miura, Yoshie
    Ishizaki, Hidenobu
    Yoshimura, Kiyoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Development of NKG2D chimeric antigen receptor-T cells as targeted therapy of liver cancer
    Dai, Hong-jiu
    Yang, Dong
    Sun, Bin
    Jiang, Yu-Bo
    Jia, Ru
    Xu, Jian-Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345